Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

338
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
338
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

249
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
249
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

319
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
319

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI counseling agent for motivational interviewing: Conversational processes associated with change talk in emergency department patients.

Journal of substance use and addiction treatment·2026
Same author

Machine-learning-enabled modeling of pharmacokinetics and pharmacodynamics.

Drug discovery today·2026
Same author

The Role of Ventricular Arrhythmias Inducibility in Arrhythmic Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: A Meta-Analysis of Observational Studies.

Journal of arrhythmia·2025
Same author

Feasibility and Acceptability of a Large Language Model-Based Motivational Interviewing Agent in the Emergency Department.

Annals of emergency medicine·2025
Same author

Application of machine learning in combination with mechanistic modeling to predict plasma exposure of small molecules.

Frontiers in systems biology·2025
Same author

Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery of antibodies.

mAbs·2025
Same journal

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Butorphanol Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework.

CPT: pharmacometrics & systems pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

1.9K

QPRapp: A Web-Based Platform for PK/PD Simulations and Early Feasibility Analysis.

Saroj Dhakal1, Yorgos M Psarellis1, Nikhil Pillai1

  • 1Quantitative Pharmacology-Pharmacometrics-Research, Translational Medicine Unit (TMU), Sanofi, Cambridge, Massachusetts, USA.

CPT: Pharmacometrics & Systems Pharmacology
|September 16, 2025
PubMed
Summary
This summary is machine-generated.

Quantitative pharmacology research application (QPRapp) simplifies dose-exposure and PK/PD assessments for small and large molecules. This tool aids drug discovery by enabling target occupancy calculations and simulations for various drug types.

Keywords:
early feasibility analysismodel‐informed drug developmentpharmacokinetic/pharmacodynamicshiny application

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

Related Experiment Videos

Last Updated: Jan 17, 2026

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

1.9K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Drug Development

Background:

  • Quantitative pharmacology research requires robust tools for evaluating dose-exposure relationships and pharmacokinetic/pharmacodynamic (PK/PD) assessments.
  • Assessing complex molecules like bi- and tri-specific drugs, including target occupancy, presents computational challenges.
  • Model-informed drug development (MIDD) is crucial for early-stage drug discovery but often requires specialized expertise.

Purpose of the Study:

  • To introduce Quantitative Pharmacology Research Application (QPRapp), a user-friendly web-based interface.
  • To facilitate PK/PD assessment, dose-exposure relationship evaluation, and target occupancy calculations for diverse molecules.
  • To support early feasibility analysis (EFA) and target-mediated drug disposition (TMDD) simulations.

Main Methods:

  • Developed a Shiny for Python web application, QPRapp.
  • Incorporated a streamlined dashboard with multiple input options via drop-down menus.
  • Enabled user specification of molecule type (small/large), model compartments (1-2), and number of targets (1-3 for large molecules).
  • Integrated four indirect response PK/PD models for small molecule simulations.
  • Included features for TMDD and EFA for multi-specific molecules.

Main Results:

  • QPRapp provides an interactive platform for PK/PD simulations.
  • Users can easily evaluate dose-exposure relationships and calculate target occupancy.
  • Simulated scenarios can be exported as CSV files for further analysis.
  • The application supports complex assessments for mono-, bi-, and tri-specific molecules.

Conclusions:

  • QPRapp democratizes quantitative pharmacology research by offering an accessible tool.
  • It empowers project teams with limited computational expertise to apply MIDD principles early in drug discovery.
  • The application enhances the evaluation of dose-exposure relationships and PK/PD for a wide range of molecules.